SCHAUMBURG, IL -- Wellness Center USA, Inc. (WCUI), a Schaumburg, IL company focused in the healthcare, alternative healthcare and medical device industries, today announced that it has engaged Institutional Analyst Inc., (IAI) a highly regarded investment research and public relations firm, specializing in market awareness programs for publicly-traded companies. The firm provides coverage in numerous industries via industry specific financial web portals and newsletters including the Internet, Biotech, Alternative Energy, Entertainment and the Private Equity markets.
“We are excited to initiate coverage on Wellness Center USA following the successful acquisition of two leading alternative health companies, which offer drug-free solutions to markets with combined drug related revenues in excess of $25 billion”, stated Roland Rick Perry, Managing Director of IAI.
“Both companies are at the forefront of drug free treatment for ailments which when treated with drugs, can contribute to a host of potentially serious and undesirable side effects. CNS Wellness which was acquired in early August of 2012, has a proven drug-free solution to treat a variety of mental health issues including; severe depression, post-traumatic stress disorder (PTSD) and autism utilizing proprietary real-time neurofeedback and neurostimulation training combined with sophisticated QEEG brain mapping and progress monitoring. In use and refined over a six years period, CNS represents a paradigm shift in the way in which medical professionals can treat and address mental health issues. Anti-psychotics drugs alone net the pharmaceutical industry at least $14.6 billion dollars a year. The opportunity to treat mental health problems without the use of drugs, with a proven track record of 65-90%, is enormous. We are excited to follow and report on their progress as they seek to achieve their goal of opening a nationwide chain of clinics to treat patients using this safe, revolutionary and proprietary technology”, he added.
Mr. Perry continues, “In the case of Psoria-Shield, which was acquired in late August of 2012 and which is a medical device developer, manufacturer and marketer, they have a drug free treatment for a host of skin ailments including Psoriasis, Eczema and Vitiligo. Their flagship product, Psoria-Light is FDA cleared and the first in the world to utilize highly effective Deep targeted UV LED technology to treat these skin ailments. The device has the potential to displace Excimer lasers in the use of skin disorders. Targeted UV phototherapy refers to administering large doses of UV light to only affected skin, sparring healthy skin tissue. Recent statistics indicated that more than $11.25 billion is spent annually in the US to treat psoriasis alone with the National Psoriasis Foundation (NRF) believing 2-3% of the world population being affected. Further, recent surveys conducted by the NRF indicated that at least 50% of sufferers were receiving no treatment and that prescriptions were widely utilized and that UV therapy was under-utilized. Psoria-Light sales are underway and we are excited to follow and report on their progress as they begin a national roll-out with independent medical sales device specialists. Nationwide, they will market the Psoria-Light directly to dermatologists based in private practice and hospitals. With a retail selling price of $64,000 and an investment payback time a short as 5 months, we are extremely excited about the sales potential for 2013 and years to come.”
Institutional Analyst Inc., has prepared a 15 page report on Wellness Center USA which will be delivered to its subscriber base and is available for non-subscribers at the Biotech Stock Review website. A copy of the report can be downloaded at www.biotechstockreview.com or http://goo.gl/ZGQKR. Please see report specific related disclaimers attached to the report.
About Institutional Analyst Inc.
Institutional Analyst Inc., headquartered in Chicago, introduces small and micro-cap companies to professional investors including investment brokers, small cap mutual funds, private investment managers and hedge fund managers. The firm operates a number of leading industry specific websites, including the Internet Stock Review, the Biotech Stock Review, the Hollywood Stock Review, the Restaurant Stock Review, the Private Equity Stock Review and Patent Stock Review, which are all available free to professional and retail investors and to industry and trade executives.
About Wellness Center USA, Inc. http://wellnesscenterusa.com/
Wellness Center USA, Inc. was created to address important healthcare and wellness needs; through break-through solutions, centered on the "well-being of the body and mind". Wellness Center USA, Inc.'s three business units are:
AminoFactory (www.aminofactory.com), a division of Wellness Center USA, Inc., is an online supplement store where health conscious consumers can make informed decisions about purchasing the highest quality amino acids and other nutritional products in just a few clicks.
CNS-Wellness (www.cns-wellness.com) is a Tampa FL based cognitive science clinic business, specializing in the treatment of behavioral health disorders in at least three focus areas: a) stress related disorders including anxiety and panic attacks, depression, and obsessive-compulsive spectrum disorders, b) developmental and learning disorders such as autistic spectrum issues and Asperser's syndrome, AD/HD, learning differences and birth trauma-related issues, and c) purely brain-based issues including epilepsy and seizure disorder, traumatic brain injuries, and related acquired brain syndromes.
Psoria-Shield Inc. (www.psoria-shield.com) is a Tampa FL based company specializing in design, manufacturing, and distribution of medical devices to domestic and international markets. PSI employs full-time engineering, production, sales staff, and manufactures within an ISO 13485 certified quality system. PSI's flagship product, Psoria-Light®, is FDA-cleared and CE marked and delivers targeted UV phototherapy for the treatment of certain skin disorders.
Safe Harbor Statement:
Certain statements contained in this news release that are not statements of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include statements regarding the proposed exchange transaction, the anticipated closing date of the transaction and anticipated future results following a closing of the transaction. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "estimate," and "intend" or future or conditional verbs such as "will," "would," "should," "could," or "may." While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transaction, and which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transaction, difficulties in integrating operations following the transaction, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.
SOURCE Wellness Center USA, Inc.
Andrew J. Kandalepas